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DOI: 10.1039/c0an00215aBased on Exonuclease III (Exo III) and displacing probes, we have developed a Cyclic Enzymatic
Amplification Method (CEAM) for sensitive and selective detection of nucleic acids. In this design, the
displacing probe is non-fluorescent on its own and cannot be digested by Exo III until displacement
hybridization by a target sequence, leading to release of free non-quenched fluorophore. Because
a single target sequence can lead to the release and digestion of numerous fluorophore strands from the
displacing probe, a remarkable signal amplification is achieved. With this method, DNA can be
detected in the picomolar range with a high selectivity and within less than 20 min.Introduction
The ability to sense and detect ultralow concentrations of specific
nucleic acid sequences is important in clinical diagnostics and
biodefense applications.1 Among many methods developed for this
purpose, amplification is one of the most significant ways because it
offers the highest analytical sensitivity.2 There are two types of
amplification that have been widely used: target sequence ampli-
fication and signal amplification. Target sequence amplification
amplifies target sequence to such a level that is detectable with
traditional assays, while a signal amplification method utilizes
enzymatic reaction or other signal amplification mechanism to
transduce target binding events to measurable signal. Typical
examples of target amplification include polymerase chain reaction
(PCR),3 rolling circle amplification (RCA)4 and their derived
techniques, such as helicase-dependent amplification (HDA)5 etc.
These sequence amplification techniques have the advantages of
high sensitivity and selectivity (single nucleotide discrimination),
but they are also limited by a series of drawbacks including complex
treatment procedures, easy contamination and high costs.6
In contrast, signal amplification methods, such as nicking
enzyme signal amplification (NESA)6a,7 and autonomous repli-
cation of DNA/FokI cutter units,8 have been developed for
simple and convenient DNA detection. These amplification
methods are simple, and also do not require expensive instru-
ments. However, one of the common limitations of these enzyme
signal amplifications is that the enzyme used requires target
DNA with a specific sequence for enzyme recognition, such as
‘‘–GATCC–’’ for Nicking endonuclease and ‘‘–CATCC–
GGATG–’’ for FokI Enzyme, thus set an restriction on target
sequence selections.9 Consequently, a novel platform for sensi-
tive and selective monitoring of any nucleic acid sequence with
rapid, simple manipulation is greatly desired.
Toward this end, Zuo et al. have developed an Exo III-aided
target recycling method for sensitive and selective amplifiedState Key Laboratory for Physical Chemistry of Solid Surfaces, The Key
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This journal is ª The Royal Society of Chemistry 2010fluorescence DNA detection.10 The method uses Exo III for
enzymatic cleavage while a molecular beacon as a signalling
probe. The amplified DNA assay is designed in such a way that
once a molecular beacon recognizes and hybridizes to its target
sequence to form a blunt 30 terminus, it will be immediately
digested by Exo III to produce free un-quenched fluorophore and
ultimately releasing the target. The released target can then
hybridize with another, whence the cycle starts anew, leading to
significant amplification of the signal. The approach achieves
picomolar detection simply by mixing the modified molecular
beacon, Exonuclease III, and complementary target DNA and
incubating for 2 h at 37 C. The method does not require
a specific recognition site in the target sequence because Exo III is
a sequence-independent enzyme. However, as a single strand
stem-loop hairpin probe, molecular beacons are difficult to
design and expensive to make.11
In this paper, we report an enzymatic signal amplification
method based on Exo III13 and displacing probe,12,14 called
Cyclic Enzymatic Amplification Method (CEAM) for simple,
rapid, sensitive, selective and inexpensive detection of nucleic
acids. Displacing probes, developed by Li et al. based on the
principle of displacement hybridization,12 consists of two
complementary oligonucleotides of different lengths labelled
with fluorophore and quencher respectively. In comparison with
molecular beacons, these probes are much easier to design,
synthesize, purify and thus cheaper and easier to use. In our
design, the displacing probe is non-fluorescent on its own and
cannot be digested by Exo III until displacement hybridization
by a target sequence, leading to the release of free non-quenched
fluorophore. Because a single target sequence can lead to the
release and digestion of numerous fluorophore strands from the
displacing probe, a remarkable signal amplification is achieved.
With this method, DNA can be detected in the picomolar range
with single base discrimination selectivity within less than 20 min.Results and discussion
Principle of CEAM
The principle of CEAM is shown in Fig. 1. This system






























































View Onlinethe stepwise removal of mononucleotides from blunt or recessed
30-hydroxyl termini of duplex DNA, while it is less active on
single-stranded DNA or 30 protruding termini of double-
stranded DNA. The displacing probe is composed of two
complementary oligonucleotides of different lengths. The longer
positive strand is labelled with a fluorophore at the 50-end and
the shorter negative strand is labelled with a quencher at the 30-
terminus, so that the fluorophore and the quencher groups are in
close proximity in the duplex probe.12 Thus, in the absence of
target DNA, the probe is non-fluorescent due to the quenching
of the fluorophore by the quencher. In the presence of target
DNA, the quencher strand can be displaced and the fluorophore
becomes fluorescent because the formation of a much stable and
longer Fluorophore probe/target duplex. More importantly,
after binding to the target, the 30 of the fluorophore strand
changes from 30 protruding to a recessed terminus and becomes
an ideal substrate for Exo III digestion. As a result, target
binding to the fluorophore strand leads to digestion of the
fluorophore strand and subsequently releasing the target DNA
strand to bind to another 30-protruding termini double stranded
probe to initiate the next round of cleavage. This cyclic reaction
will repeat again and again until all double stranded probes are
consumed and all fluorophores light up, resulting in a significant
fluorescent signal amplification. Ultrasensitive detection of
DNA can be achieved because in principle a single copy of target
DNA could lead to complete consumption of all displacing
probes present in the system and complete restoration of
fluorescence.
Traditional displacing probes with a blunt 30-terminus can be
nonspecifically cleaved by Exo III, causing a relatively high
background signal. To solve this problem, we elongated the 30-
termini of quencher strand to form a enzymatic inactive
protruding terminus. Our experiments clearly indicated that with
the lengthening of the quencher probe, background digestion of
the fluorophore probe significantly inhibited. However,
a protruding terminus that is too long would reduce the FRET
efficiency between the fluorophore and the quencher. Overall,
our experimental results indicated that a displacing probe with 4
guanine bases protruding at 30-termini of quencher probe
remarkably resists Exo III cleavage, while maintaining a low
fluorescence background.Fig. 1 Working principle of the cyclic enzymatic amplification method
(CEAM).
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As previously described, the displacing probe undergoes
a displacement hybridization with its target and provides an
active site for Exo III. Cyclic enzymatic amplification is then
triggered. As shown in Fig. 2(a), with the addition of a low
concentration of target DNA (i.e. 5 nM), fluorescence intensity
slightly increased, indicating the successful dislodgement of the
quencher probe from the fluorophore probe by a longer target
sequence. The increase of fluorescence intensity was very small
because one target sequence could only displace one quencher
strand. By contrast, a remarkable rise in fluorescence intensity
was observed upon the addition of Exo III, which was likely due
to the rapid cyclic displacement of quencher sequence by target
sequence and subsequent cleavage of the fluorophore strand by
Exo III(Fig. 2a). Further kinetic analysis of target binding
reaction and Exo III digestion indicated that the latter is orders
of magnitude faster than the former when target concentration is
in the sub-nM range, with the toehead exchange reaction being
the rate-determining step. Because a single target sequence can
lead to the release and digestion of numerous fluorophore
strands, a remarkable signal amplification was observed. Elec-
trophoresis experiment was performed, which clearly revealed
complete digestion of the fluorophore strand, while other
sequences including the quencher strand, target strand remained
intact (Fig. 2b). The results confirmed that CEAM enables
a significant signal amplification.Amplified detection of target with high sensitivity
Signal amplification nature of the CEAM enables ultrahigh
sensitive DNA detection. Fig. 3(a) shows the fluorescence
intensity observed upon different concentrations of targets with
this method. The results showed that fluorescence intensity
increased as the concentration of the targets increased. Fig. 3(b)
shows the relationship between the fluorescence intensity and
target concentration. As the target concentration increases, the
rate of fluorescence enhancement increases. A good linear rela-
tionship between the fluorescence signal change (DF) and the
target concentration was from 0.05 nM to 2.5 nM for sensitive
quantitation with a correlation coefficient of 0.9932 for the linearFig. 2 (a) Time course study of CEAM at low target concentrations. (b)
Denatured PAGE analysis of the products by the cyclic enzymatic
amplification method. Lanes 1–6: (1): F probe + Q probe (2) F probe + Q
probe + Exo III:, (3): F probe + cDNA, (4): F probe + cDNA + Exo III,
(5): Q probe + cDNA, (6): Q probe + cDNA + Exo III. The fluorophore
probe, quencher probe and cDNA were 5.0  108 mole respectively. All
samples were incubated at RT.
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Fig. 3 (a) Detection of different concentrations of target based on
CEAM. Experiments were performed in the presence of 5U Exo III with 5
 108 M fluorophore probe, 1  107 M quencher probe, and different
concentrations of target. The curves from top to down contain the target
with 5.0  108, 2.5  108, 5.0  109, 2.5  109, 5  1010, 2.5  1010,
5  1011 and 0 M, respectively. All samples were incubated at RT. (b)
The relationship between the fluorescence enhancement and target DNA
concentration. The data shown here and in the following figures are mean































































View Onlinecalibration curve shown in the inset. The regression equation was
DF ¼ 58.98Ctarget + 7.71. Based on 3 times standard deviation of
6 measurements of blank samples, the detection limit was about
24 pM, which is comparable, or superior to existing signal
amplification technologies.15 It is worthy pointing out that such
a high sensitivity is achieved within less than 20 min. Zuo et al.
reported a detection limit of 10 pM within 30 min using Exo III
and molecular beacons,10 which is comparable to ours. The
sensitivity was reported to further improve by extending the
reaction to 24 h. However, no significant improvement of
detection limit was observed with our method even after
extending the reaction to 24 h. Of course, such a long assay time
might not be favorable for many applications where time is
a critical factor.
To confirm that the high sensitivity of DNA detection is
a result of the cyclic enzymatic amplification, control experi-
ments with target at various concentrations reacting with theFig. 4 Response of displacing probe to various concentrations of target.
Experiments were performed in the absence of Exo III with 5  108 M
fluorophore probe, 1  107 M quencher probe and different concen-
trations of target. The curves from (A) to (E) contain the target with 1 
108, 8  109,5  109, 1  109 and 0 M, respectively. All samples were
incubated at RT.
This journal is ª The Royal Society of Chemistry 2010displacing probes in the absence of Exo III were also carried out
(Fig. 4). However, the detection limit is only 1 nM, which is two
orders of magnitude less sensitive than CEAM.
Selectivity of the CEAM
Our CEAM displays an excellent detection selectivity. As shown
in Fig. 5, completely matched target triggered 12 times higher
signal change than a single-base mismatched target did. The
good selectivity probably comes from two reasons. On the one
hand, displacing probe is considered a probe with good selec-
tivity for single-base mismatch detection because of the different
melting temperature between fully matched and mismatched
target.12 On the other hand, different enzymatic activity
responding to match and mismatch target adds an extra layer of
selectivity. A complete match produces a recessed fluorophore
strand, while a mismatch would yield a protruding 30-terminus,
thus causing a significant difference on Exo III digestion activity.
The excellent selectivity of CEAM makes it a promising tech-
nique for detection of single nucleotide polymorphisms.
CEAM for detection of HFE
Based on the principle established above, one could utilize
CEAM for DNA detection in clinical diagnostics and biodefense
applications, especially disease-associated single nucleotide
polymorphisms (SNP). For instance, we designed a CEAM
probe for human hemochromatosis (HFE) gene mutation
detection. HFE gene is one of the most common single gene
disorders that causes hereditary hemochromatosis in Caucasians.
The difficulty in detecting this mutation with classical single
stranded probes lies in the fact that the G/A is the least desta-
bilized mismatch, and thus requires a probe with extremely high
specificity. Our results showed that with a CEAM approach one
can easily distinguish a mutation gene from a wild-type gene at
concentrations as low as 10 pM (Fig. 6).
Conclusions
In conclusion, we have designed a Cyclic Enzymatic Amplifi-
cation Method based on Exo III and displacing probes. The
method offers high sensitivity and excellent selectivity for nucleicFig. 5 Single-base mismatch detection using CEAM.
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Fig. 6 Detection of different concentrations of HFE target based on
CEAM. Experiments were performed in the presence of 5U Exo III with 5
 108 M fluorescence probe, 1  107 M quencher probe, and different
concentrations of target. (a) Fluorescence spectra of this amplified DNA
detection method over a range of target DNA concentrations. The curves
from top to bottom represent the target with 5  108, 2.5  108, 1.25 
108, 5  109, 2.5  109, 1.25  109, 5  1010, 2.5  1010, 1.25 
1010, 5  1011 and 0 M, respectively. All samples were incubated at RT.
(b) The relationship between the fluorescence enhancement value and
target DNA concentration. (c) The selectivity comparison of CEAM for
cDNA and single-base mismatched DNA.














































































View Onlineacid detection with rapid, simple procedures. Such a method does
not require a recognition sequence in the target DNA, thus has
much better flexibility for choosing a target sequence and
a wider applicability. CEAM can be carried out at a constant2072 | Analyst, 2010, 135, 2069–2073temperature (37 C or Room Temperature) and just with one-
step manipulation, avoiding the complex handling procedures
required by other methods like PCR or RCA. Furthermore,
a signal change can be achieved within 15 min, effectively
decreasing the time-cost of clinical diagnostics. Also, superior to
double labelling molecular beacons, displacing probes with one-
dye-labeled are easy to design and inexpensive to make.11b Based
on these advantages, CEAM should be potentially exploited in
the field of study on life science and practically applied in clinical
diagnostics, mutation detection, and biodefense applications.
Experimental
Materials
Exonuclease III was purchased from Takara Biotechnology Co.
Ltd. (Dalian, China) and used without further purification. The
probe DNA, target DNA and mismatched DNA were synthe-
sized on a PolyGen DNA synthesizer and the reagents were
purchased from Glen Research (Sterling, VA, USA). All DNA
sequences are listed in Tables 1 and 2.
DNA synthesis
DNA was synthesized on a PolyGen DNA synthesizer. A
DABCYL CPG column was used for the synthesis 30-DABCYL
labled quencher probe, while FAM phosphoramidite was used to
couple the fluorophore to the 50 ends of the Fluorophore probe.
The complete probe sequences were then deprotected in
concentrated ammonia overnight at 65 C and purified by high-
pressure liquid chromatography.16 HPLC was performed on an
Agilent 1100 series HPLC using a Promosil C18 reversed phase
column (5 mm, 250  4.6 nm). The collected product was then
vacuum-dried, desalted with a NAP-5 column, and stored at
20 C for future use. Absorbance was measured on an Agilent
8453 UV/Vis spectrometer and used to calculate the
concentration.
Fluorescence measurements
Fluorescence measurements were carried out on a RF-5301-PC
Fluorescence Spectrophotometer (Shimadzu, Japan). Excitation
and emission wavelengths were set at 490 and 517 nm, respec-
tively, with 5 nm bandwidth. The emission spectra were obtainedThis journal is ª The Royal Society of Chemistry 2010










































































View Onlineby exciting the samples at 490 nm and scanning the emission
from 500 to 650 nm in steps of 1 nm. All experiments were
conducted in 20 mM Tris-HCl (pH 8.0) buffer containing 5 mM
MgCl2 and 50 mM NaCl. The amplified detection of target were
performed in 400 ml solution consisting of 5.0  108 M fluo-
rophore probe and 1  107 M quencher probe, 5 units of
Exonuclease III and varying concentrations of DNA target at
RT for 0.5 h.Gel electrophoresis
A 20% denatured PAGE analysis of the products by the cyclic
enzymatic amplification reaction was carried out in 1  TBE
(pH 8.3) at 1 W power for about 2 h. After Stains-All staining,
gels were scanned.Acknowledgements
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